3 citations
,
January 2021 in “Actas Dermo-Sifiliográficas” This review discusses the scalp and follicular microbiome's potential role in hair diseases and the emerging interest in microbiome-targeted therapies, but reports no new clinical findings.
This study found that the patient receiving microneedling and platelet-rich plasma treatment showed earlier significant improvements and high satisfaction compared to the patient treated with microneedling and topical minoxidil.
January 2020 in “Skinmed” In this study, microneedling combined with platelet-rich plasma led to earlier improvements and high patient satisfaction in a man with androgenic alopecia, compared to microneedling with topical minoxidil.
50 citations
,
December 2008 in “Clinical Endocrinology” This study found that young males with stage III or higher androgenetic alopecia had higher insulin resistance and cardiovascular-related features, suggesting the need for metabolic assessment in this population.
December 2021 in “Cureus” This study found that for managing early-onset androgenetic alopecia in men, minoxidil monotherapy is cost-effective at a $50,000 willingness-to-pay threshold, while combining minoxidil with platelet-rich plasma becomes cost-effective at a $100,000 threshold.